Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flavonoids and nitric oxide synthase.

R Olszanecki1, A Gebska, V I Kozlovski

  • 1Jagiellonian University Medical College, Department of Pharmacology, Cracow, Poland. mfolszan@cyf-kr.edu.pl

Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|January 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiotensin 1-7 formation in breast tissue is attenuated in breast cancer - a study on the metabolism of angiotensinogen in breast cancer cell lines.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2019
Same author

Lactate in cardiogenic shock - current understanding and clinical implications.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2018
Same author

Therapeutic effect of exogenous ghrelin in the healing of gingival ulcers is mediated by the release of endogenous growth hormone and insulin-like growth factor-1.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2017
Same author

Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.

British journal of pharmacology·2016
Same author

Exogenous Angiotensin I Metabolism in Aorta Isolated from Streptozotocin Treated Diabetic Rats.

Journal of diabetes research·2016
Same author

Metabolic effects of subchronic peripheral oxytocin administration in lean and obese zucker rats.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2016

Flavonoids can inhibit the induction of nitric oxide synthase-2 (NOS-2) and may enhance nitric oxide synthase-3 (NOS-3) activity, offering potential for treating vascular inflammation and atherogenesis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Vascular inflammation, characterized by increased nitric oxide synthase-2 (NOS-2) and decreased nitric oxide synthase-3 (NOS-3) activity, is a key factor in atherogenesis.
  • Targeting NOS-2 induction is a rational therapeutic strategy, potentially more effective than inhibiting already induced NOS-2 activity.
  • Flavonoids, known NOS-3 stimulators with potential antiatherogenic effects, were investigated as inhibitors of NOS-2 induction.

Purpose of the Study:

  • To identify flavonoids that inhibit NOS-2 induction.
  • To investigate the mechanism by which flavonoids affect NOS-2 and NOS-3.
  • To explore the potential of flavonoids as therapeutic agents for vascular inflammation.

Main Methods:

  • In vitro model using LPS-treated J774.2 macrophages.

Related Experiment Videos

  • Assay of NOS-2 induction and activity using Western blotting.
  • Analysis of NOS-2 gene transcription via RT-PCR and Northern blotting.

    • Main Results:

    • None of the tested flavonoids inhibited NOS-2 activity.
    • All tested flavonoids potently inhibited NOS-2 protein induction in LPS-treated macrophages.
    • Kaempferol and apigenin were the most potent inhibitors, suppressing NOS-2 induction at the gene transcription level.

    Conclusions:

    • Certain flavonoids are potent inhibitors of NOS-2 induction.
    • These flavonoids may also enhance endothelial NOS-3 activity.
    • Flavonoids show promise as natural precursors for drugs to reverse the inflammatory component of atherothrombosis.